How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,267 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Immediate postpartum long-acting reversible contraception for women at high risk for medical complications Full Text available with Trip Pro

Immediate postpartum long-acting reversible contraception for women at high risk for medical complications SocietyforMaternal-FetalMedicine(SMFM) ConsultSeries#48:Immediatepostpartum long-actingreversiblecontraceptionforwomen athighriskformedicalcomplications Society for Maternal-Fetal Medicine (SMFM); Laura K. Vricella, MD; Lori M. Gawron, MD, MPH; Judette M. Louis, MD, MPH The Society of Family Planning (SFP) endorses this document. The American College of Obstetricians and Gynecologists (...) Organization Title Yearof publication American College of Obstetricians and Gynecologists Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception 2016 Centers for Disease Control and Prevention U.S. Medical Eligibility Criteria for Contraceptive Use 2016 American College of Obstetricians and Gynecologists Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. 2017 Society of Family Planning Society of Family Planning Guidelines

2019 Society for Maternal-Fetal Medicine

2. Society of Family Planning clinical recommendations: contraception after surgical abortion Full Text available with Trip Pro

-Ma C. et al. Impact of a theory-based video on initiation of long-acting reversible contraception after abortion. Am J Obstet Gynecol. 2015; 212 ( [Evidence Grade: I] ) : 310.31-7 ] resulted in no difference in contraceptive uptake or method choice. A systematic review of periabortion counseling models showed no effect on subsequent unintended pregnancy, although the sample size of studies was small and heterogeneous [ Stewart H. McCall S.J. McPherson C. Towers L.C. Lloyd B. Fletcher J. et al (...) reversible contraceptive methods. Perspect Sex Reprod Health. 2014; 46 ( [Evidence Grade: III] ) : 171-175 , Moniz M.H. Spector-Bagdady K. Heisler Michele Harris L.H. Inpatient postpartum long-acting reversible contraception. Obstet Gyncol. 2017; 130 ( [Evidence Grade: III] ) : 783-787 ]. 2 Which short-acting reversible contraceptive methods can be initiated after surgical abortion? Any short-acting contraceptive method may be started immediately after first- or second-trimester surgical abortion (GRADE

2020 Society of Family Planning

3. Covid-19: Society of Family Planning interim clinical recommendations: Contraceptive provision when healthcare access is restricted due to pandemic response

. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65. https://doi.org/10.15585/mmwr.rr6504a1. [9] National Family Planning & Reproductive Health Association. NFPRHA Resource: Self- Administration of Injectable Contraception 2020. https://www.nationalfamilyplanning.org/file/documents---service-delivery-tools/NFPRHA--- Depo-SQ-Resource-guide---FINAL-FOR-DISTRIBUTION.pdf (accessed April 21, 2020). [10] SisterSong, National Women’s Health Network. Long-Acting Reversible (...) Covid-19: Society of Family Planning interim clinical recommendations: Contraceptive provision when healthcare access is restricted due to pandemic response Society of Family Planning interim clinical recommendations: Contraceptive provision when healthcare access is restricted due to pandemic response Lyndsey S. Benson, MD, MS a ; Tessa Madden, MD, MPH b ; Jessica Tarleton, MD, MPH c ; Elizabeth A. Micks, MD, MPH a a University of Washington, Seattle, WA, USA b Washington University in St

2020 Society of Family Planning

4. Immediate versus delayed postpartum insertion of contraceptive implant for contraception. Full Text available with Trip Pro

Immediate versus delayed postpartum insertion of contraceptive implant for contraception. The spacing of pregnancies has a positive impact on maternal and newborn health. The progestin contraceptive implant, which is a long-acting, reversible method of contraception, has a well-established low failure rate that is compatible with tubal sterilization. The standard provision of contraceptive methods on the first postpartum visit may put some women at risk of unintended pregnancy, either due (...) to loss to follow-up or having sexual intercourse prior to receiving contraception. Therefore, the immediate administration of contraception prior to discharge from the hospital that has high efficacy may improve contraceptive prevalence and prevent unintended pregnancy.To compare the initiation rate, effectiveness, and side effects of immediate versus delayed postpartum insertion of implant for contraception.We searched for eligible studies up to 28 October 2016 in the Cochrane Central Register

2017 Cochrane

5. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices e130 VOL. 131, NO. 5, MAY 2018 OBSTETRICS & GYNECOLOGY Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices ABSTRACT: The phenomenon of adolescent childbearing is complex and far reaching, affecting not only the adolescents but also their children and their community. The prevalence and public health effect of adolescent pregnancy reflect complex structural social problems (...) and an unmet need for acceptable and effective contra- ceptive methods in this population. In 2006–2010, 82% of adolescents at risk of unintended pregnancy were currently using contraception, but only 59% used a highly effective method, including any hormonal method or intrauterine device. Long-acting reversible contraceptives (LARC) have higher efficacy, higher continuation rates, and higher satisfaction rates compared with short-acting contraceptives among adolescents who choose to use them

2018 American College of Obstetricians and Gynecologists

6. Interventions using social networking sites to promote contraception in women of reproductive age. Full Text available with Trip Pro

studies were conducted in the USA and were at high risk of bias. One RCT included 2284 women exposed to a web-based SNS or nothing. The groups were no different post intervention in their self-reported consistency of contraceptive use or knowledge of the relative effectiveness of different methods. There was a small but significant increase in the use of more effective methods (long-acting reversible methods) at 12 months' follow-up.The second study, a cluster RCT with 1578 women, used a closed (...) Interventions using social networking sites to promote contraception in women of reproductive age. Social networking sites (SNSs) have great potential as a platform for public health interventions to address the unmet need for contraception.To evaluate the effectiveness of interventions using SNSs to promote the uptake of and adherence to contraception in reproductive-age women.We searched CENTRAL, MEDLINE, Embase, and six other databases on January 2018. We also searched Google Scholar, key

2019 Cochrane

7. Contraception

/peoplepopulationandcommunity/birthsdeathsandmarriages/conceptionandfertilityrates/bulletins/conceptionstatistics/2016 National Institute for Health and Care Excellence. Long-acting reversible contraception. September 2014 [internet publication]. http://www.nice.org.uk/guidance/cg30 In the US, which has one of the highest rates of unintended pregnancy in the developed world, about half of all pregnancies are unintended. Of these, approximately 40% end in abortion. Hatcher R. Contraceptive technology. 20th ed. New York (...) group abortion rates and lifetime incidence of abortion: United States, 2008-2014. Am J Public Health. 2017 Dec;107(12):1904-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678377/ http://www.ncbi.nlm.nih.gov/pubmed/29048970?tool=bestpractice.com This disparity suggests that there is limited access to contraception for some women and adolescents, and points to the importance of addressing birth control with all patients at risk of unintended pregnancy. Availability of contraceptives differs between

2018 BMJ Best Practice

8. Beyond same-day long-acting reversible contraceptive access: a person-centered framework for advancing high-quality, equitable contraceptive care. Full Text available with Trip Pro

Beyond same-day long-acting reversible contraceptive access: a person-centered framework for advancing high-quality, equitable contraceptive care. In the last decade-plus, there has been growing enthusiasm for long-acting reversible contraceptive methods as the solution to unintended pregnancy in the United States. Contraceptive access efforts have primarily focused on addressing provider and policy barriers to long-acting reversible contraception and have promoted long-acting reversible (...) contraception as first-line methods through marketing and tiered-effectiveness counseling. A next generation of contraceptive access efforts has the opportunity to move beyond this siloed focus on long-acting reversible contraception toward a focus on equity and person-centeredness. Here we define a new framework for increasing equitable access to high-quality, person-centered contraceptive care that includes programmatic elements necessary to provide information and services to address the barriers

2020 American Journal of Obstetrics and Gynecology

9. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial. Full Text available with Trip Pro

Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial. Long-active reversible contraceptives reduce unintended pregnancy and abortions, but uptake is low. Interventions to increase uptake in family medicine settings are untested.The Australian Contraceptive ChOice pRoject, which was adapted from the successful US Contraceptive CHOICE study, aimed to evaluate whether a complex intervention in family medicine practices (...) resulted in increased long-active reversible contraceptive uptake.This cluster randomized controlled trial was set in family practices in metropolitan Melbourne, Australia. From April 2016 to January 2017, we recruited 57 family physicians by mail invitation. Each family physician aimed to recruit at least 14 female patients. Eligible family physicians worked ≥3 sessions per week in computerized practices. Eligible women were English-speaking, sexually active, not pregnant, not planning a pregnancy

2020 American Journal of Obstetrics and Gynecology

10. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. Full Text available with Trip Pro

Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. Contraceptive choice is a preference-sensitive decision that is affected by contraceptive attributes, patient experience, and reproductive history. Familiarity with and acceptability of specific contraceptive methods may influence patient decisions.The purpose of this study was to describe the acceptability of and previsit familiarity with long-acting reversible contraception (intrauterine devices (...) acceptability (7-10) and low/moderate acceptability (0-6) for analysis. We examined differences in demographic and reproductive characteristics between women with high and low long-acting reversible contraception acceptability using the chi-square test. We used univariate and multivariable Poisson regressions to examine the relationship among participants' characteristics, method acceptability, and method choice. We adjusted for any covariate that changed the effect size of acceptability by >10%.There were

2020 American Journal of Obstetrics and Gynecology

11. Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Long-Acting Reversible Contraception: Implants and Intrauterine Devices Long-Acting Reversible Contraception: Implants and Intrauterine Devices - ACOG Menu ▼ Long-Acting Reversible Contraception: Implants and Intrauterine Devices Page Navigation ▼ Number 186, November 2017 (Replaces Practice Bulletin Number 121, July 2011) Committee on Practice Bulletins—Gynecology . This Practice Bulletin was developed by the Committee on Practice Bulletins—Gynecology and the Long-Acting Reversible (...) , incurred in connection with this publication or reliance on the information presented. Long-Acting Reversible Contraception: Implants and Intrauterine Devices Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use

2017 American College of Obstetricians and Gynecologists

12. Long-acting reversible contraception acceptability and satisfaction is high among adolescents

Long-acting reversible contraception acceptability and satisfaction is high among adolescents Long-acting reversible contraception acceptability and satisfaction is high among adolescents | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Long-acting reversible contraception acceptability and satisfaction is high among adolescents Article Text Commentary: Maternal and child health Long-acting reversible contraception acceptability

2017 Evidence-Based Medicine

13. Contraceptive care for Canadian youth

Contraceptive care for Canadian youth Sexual and reproductive health is an important component of comprehensive health care for youth. This statement provides guidance for selecting and prescribing contraceptives for youth, including commonly prescribed hormonal contraceptives—the pill, patch, ring and injectable progestin—and long-acting reversible contraceptives (LARCs). LARCs, including subdermal implants (which are not available in Canada) and intrauterine contraceptives (IUCs (...) contraception; Intrauterine contraception; Long-acting reversible contraception (LARC); Sexual and reproductive health

2018 Canadian Paediatric Society

14. Contraceptive Choices for Young People

ABBREVIATIONS USED BMD bone mineral density BMI body mass index BASHH British Association for Sexual Health and HIV CEU Clinical Effectiveness Unit CHC combined hormonal contraception COC combined oral contraception Cu-IUD copper-bearing intrauterine device DMPA depot medroxyprogesterone acetate EC emergency contraception FSRH Faculty of Sexual and Reproductive Healthcare HIV human immunodeficiency virus HPV human papillomavirus IUD intrauterine device LARC long-acting reversible contraception LNG-IUS (...) of pregnancy, 78% were using the contraceptive pill and/or the condom (46% and 47%, respectively, 15% used both). 31 Long-acting reversible methods of contraception (LARC) (i.e. the progestogen-only implant, injectable and intrauterine methods) are used by a minority of women, 31 but there is a trend towards increasing use. 32 Use of the progestogen-only injectable and implant is greater in young women compared with older women. 31 Young women’s choice of contraception may be influenced by a number

2019 Faculty of Sexual & Reproductive Healthcare

15. Overweight, Obesity and Contraception

oral contraception/contraceptive Cu-IUD copper intrauterine device CVD cardiovascular disease DMPA depot medroxyprogesterone acetate DSG desogestrel EC emergency contraception EE ethinylestradiol ENG etonogestrel FSRH Faculty of Sexual & Reproductive Healthcare GDG guideline development group HCP healthcare practitioner HFI hormone-free interval HMB heavy menstrual bleeding HR hazard ratio IMP progestogen-only implant IUC intrauterine contraception/contraceptive LARC long-acting reversible (...) Overweight, Obesity and Contraception FSRH Guideline Overweight, Obesity & Contraception April 2019 | FSRH Faculty of Sexual & Reproductive Healthcare (FSRH) provided funding to the Clinical Effectiveness Unit (of the FSRH) to assist them in the production of this guideline, Overweight, Obesity and Contraception (April 2019). Published by the Faculty of Sexual & Reproductive Healthcare. Registered in England No. 2804213 and Registered Charity No. 1019969. Copyright © Faculty of Sexual

2019 Faculty of Sexual & Reproductive Healthcare

16. Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?

use’ includes user error (for example, missed pills, starting a pack late) or use in circumstances that decrease efficacy such as interactions with concomitant medicines. Highly effective methods have typical-use failure rates of less than 1% and include male or female sterilisation and long-acting reversible contraceptive (LARC) methods (intrauterine devices and implants). Progestogen-only injections have a typical-use failure rate of 6%, but this may be due to repeat injections being (...) use’). Risk of user error is higher for daily methods than for long-acting reversible contraceptive (LARC) methods and is highest for methods used at time of sexual intercourse Choice of contraceptive method is an individual one and can depend on a number of clinical factors as well as the woman’s personal preference (see and from the Faculty of Sexual and Reproductive Health [FSRH]). However, different methods have different typical-use failure rates and durations of action, which can affect

2019 MHRA Drug Safety Update

17. Over-the-Counter Access to Hormonal Contraception

. A Contraceptive CHOICE Project secondary data analysis found that of 1,010 adolescents and adult women who desired a combined hormonal contraceptive method, 70 women (6.9%) self-reported having a poten- tial medical contraindication on their baseline question- naire (42). The Contraceptive CHOICE Project included females aged 14–45 years. Those who chose combined hormonal contraception at baseline were younger (mean age of 23.7 years) than those who chose long-acting reversible contraceptive methods (mean age (...) ). Notably, reasons for discontinuation of contraception are complex and include the desire for pregnancy, although reduction of barriers to access is important for those individuals who wish to con- tinue their preferred method of contraception. A study of nearly 1,000 OCP users (half of whom obtained their pills from an over-the-counter pharmacy in Mex- ico and half of whom obtained pills by prescription from a family planning clinic in El Paso, Texas) re- ported that at 9 months, 79.2% of the over

2019 American College of Obstetricians and Gynecologists

18. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents. (Abstract)

Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents. Increased use of long-acting reversible contraception (LARC; intrauterine devices [IUDs] and implants) has likely contributed to declining US teenage pregnancy and birth rates, yet sexually transmitted infection (STI) rates among teenagers remain high. While LARC methods are highly effective for pregnancy prevention, they, as with all nonbarrier methods (...) , do not protect against STIs, including HIV. Studies of the general adolescent population suggest condom use is lower among LARC vs non-LARC hormonal methods users (birth control pill, contraceptive patch, vaginal ring, or injection). Despite the high use of LARC among postpartum teenagers, no studies have examined whether condom use differs by contraceptive method in this population.To compare condom use among sexually active postpartum teenagers using LARC vs those using non-LARC hormonal

2019 JAMA pediatrics

19. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon. Full Text available with Trip Pro

Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon. Meeting targets of the Sustainable Development Goals in the domain of maternal health and the Family Planning 2020 commitments for Cameroon requires an increased use of modern contraception. Long acting reversible contraceptives (LARCs) are methods which have been proven highly efficient with contraceptive failure rates of less than 1%. The objective of this survey was to determine (...) rate of use of LARCs is still very low among these women. The number of living children is significantly associated with the use of LARCs. The local family planning policy makers should intensify sensitization on the benefits and side effects of modern contraception and LARCs in order to create more awareness and improve contraceptive uptake.

2018 PLoS ONE

20. Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC)

Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) L Long-acting re ong-acting rev versible contr ersible contraception: aception: subcutaneous depot medro subcutaneous depot medroxyprogesterone xyprogesterone acetate (DMP acetate (DMPA A-SC) -SC) Evidence summary Published: 28 January 2014 nice.org.uk/guidance/esnm31 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in January (...) that compared subcutaneous and Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) (ESNM31) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 19intramuscular administration of DMPA over 2 years with an optional 1-year extension, and also evaluated the effect of DMPA on BMD (Kaunitz et al. 2009); the other 2 studies were 1-year non- comparative studies (Jain et al. 2004

2014 National Institute for Health and Clinical Excellence - Advice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>